Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 1692 Records) |
Query Trace: Neoplasms and PIK3CA[original query] |
---|
Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in Taiwan. Breast cancer (Tokyo, Japan) 2023 12 . Bo-Fang Chen, Yi-Fang Tsai, Pei-Ju Lien, Yen-Shu Lin, Chin-Jung Feng, Yen-Jen Chen, Han-Fang Cheng, Chun-Yu Liu, Ta-Chung Chao, Jiun-I Lai, Ling-Ming Tseng, Chi-Cheng Hua |
The genomic and immune landscapes of gastric cancer and their correlations with HER2 amplification and PD-L1 expression. Cancer medicine 2023 12 . Xiaoqian Jing, Zhiping Luo, Jiayan Wu, Feng Ye, Jianfang Li, Zijia Song, Yaqi Zhang, Minmin Shi, Huaibo Sun, Yi Fang, Yimei Jiang, Xiaopin |
Genetic and clinical landscape of ER?+?/PR- breast cancer in China. BMC cancer 2023 12 23 (1): 1189. Danian Dai, Hongmei Wu, Hongkai Zhuang, Rong Chen, Cheng Long, Bo Ch |
A Novel Germline Mutation of BRCA1 and Integrated Analysis With Somatic Mutation in a Chinese Multi-Cancer Family. The oncologist 2023 12 . Xiling Yang, Li Shang, Liren Yang, Landi Sun, Xiaoqian Tuo, Sijia Ma, Le Zhao, Xu Li, Wenfang Ya |
Comparative genomic analysis of PIK3R1-mutated and wild-type breast cancers. Breast cancer research and treatment 2023 12 . Melody A Cobleigh, Kayla Viets Layng, Elizabeth Mauer, Brett Mahon, Adam J Hockenberry, Abde M Abukhde |
Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first-line setting. Cancer reports (Hoboken, N.J.) 2023 12 e1966. R Gencheva, M Petrova, P Kraleva, S Hadjidekova, M Radanova, N Conev, D Stoyanov, J Arabadjiev, E Tazimova, S Bachurska, M Eneva, M Tsvetkova, G Zhbantov, T Karanikolova, D Manov, A Ivanova, M Taushanova-Hadjieva, R Staneva, E Dimitrova, I Don |
Association of PIK3CA Mutation With Pathologic Complete Response and Outcome by Hormone Receptor Status and Intrinsic Subtype in Early-Stage ERBB2/HER2-Positive Breast Cancer. JAMA network open 2023 12 6 (12): e2348814. Paola Zagami, Aranzazu Fernandez-Martinez, Naim U Rashid, Katherine A Hoadley, Patricia A Spears, Giuseppe Curigliano, Charles M Perou, Lisa A Car |
Association of ESR1 germline variants with TP53 somatic variants in breast tumors in a genome-wide study. medRxiv : the preprint server for health sciences 2023 12 . Nijole P Tjader, Abigail J Beer, Johnny Ramroop, Mei-Chee Tai, Jie Ping, Tanish Gandhi, Cara Dauch, Susan L Neuhausen, Elad Ziv, Nereida Sotelo, Shreya Ghanekar, Owen Meadows, Monica Paredes, Jessica Gillespie, Amber Aeilts, Heather Hampel, Wei Zheng, Guochong Jia, Qiang Hu, Lei Wei, Song Liu, Christine B Ambrosone, Julie R Palmer, John D Carpten, Song Yao, Patrick Stevens, Weang-Kee Ho, Jia Wern Pan, Paolo Fadda, Dezheng Huo, Soo-Hwang Teo, Joseph Paul McElroy, Amanda Ewart Tola |
Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants. Breast cancer research and treatment 2023 12 . Christopher J Schwartz, Nikka Khorsandi, Amie Blanco, Rita A Mukhtar, Yunn-Yi Chen, Gregor Krin |
Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer. BMC medicine 2023 12 21 (1): 493. Zhaoyun Liu, Bo Yu, Mu Su, Chenxi Yuan, Cuicui Liu, Xinzhao Wang, Xiang Song, Chao Li, Fukai Wang, Jianli Ma, Meng Wu, Dawei Chen, Jinming Yu, Zhiyong |
Higher TP53 somatic mutation prevalence from liquid biopsy analysis in ever smoker non-small-cell lung cancer patients. Mutation research 2023 12 828 111847. Haktan Ba??? Erdem, Mustafa Tar?k Alay, Zeynep Özdemir, Ezgi Çevik, Öztürk Ate?, Cengiz Karaçin, ?brahim ?ahin, Mutlu Do?an, Taha Bah |
Serial circulating-tumor DNA analysis with a tumor naïve next-generation sequencing panel detects minimal residual disease and predicts outcome in ovarian cancer. Cancer research 2023 12 . Jinho Heo, Yoo-Na Kim, Saeam Shin, Kyunglim Lee, Ji-Hyun Lee, Yong Jae Lee, Zisun Choi, Jihyang Park, Seungki Min, Sang Wun Kim, Jong Rak Choi, Sunghoon Kim, Seung-Tae Lee, Jung-Yun L |
Association of KRAS, NRAS, BRAF and PIK3CA gene mutations with clinicopathological features, prognosis and ring finger protein 215 expression in patients with colorectal cancer. Biomedical reports 2023 11 19 (6): 104. Jing-Bo Wu, Xiao-Jing Li, Hui Liu, Yong-Juan Liu, Xiu-Ping L |
Mutational Landscape and In-Silico Analysis of TP53, PIK3CA, and PTEN in Patients with Breast Cancer from Khyber Pakhtunkhwa. ACS omega 2023 11 8 (45): 43318-43331. Hilal Ahmad, Asif Ali, Roshan Ali, Ali Talha Khalil, Ishaq Khan, Mah Muneer Khan, Mohammed Alori |
Mutational and expressional association of the PIK3CA gene with the risk of breast cancer in the Pakistani population. Cellular and molecular biology (Noisy-le-Grand, France) 2023 11 69 (11): 1-8. Samina Asghar Abbasi, Rashida Khan, Mehvish Naseer Ahmed, Kashif Hussain, Aayesha Riaz, Qaisar Mansoor, Mazhar Qayyum, Ruqia Mehmood Ba |
Prognostic potential of whole exome sequencing in the clinical management of metachronous colorectal cancer liver metastases. Cancer cell international 2023 11 23 (1): 295. Lucie Heczko, Viktor Hlavá?, Petr Holý, Pavel Dvo?ák, Václav Liška, Ond?ej Vy?ítal, Ond?ej Fiala, Pavel Sou? |
Recurrent Somatic Copy Number Alterations and Their Association with Oncogene Expression Levels in High-Grade Ovarian Serous Carcinoma. Life (Basel, Switzerland) 2023 11 13 (11): . Hillary P Esplen, Richard K Yang, Awdhesh Kalia, Zhenya Tang, Guilin Tang, L Jeffrey Medeiros, Gokce A Torun |
Genetic profile of Chinese patients with small bowel cancer categorized by anatomic location. BMC medical genomics 2023 11 16 (1): 289. Chengmin Shi, Junrui Ma, Tong Zhang, Yanqiang Shi, Weiming Duan, Depei Huang, Hushan Zhang, Yujian Ze |
A comparison between mutational profiles in tumour tissue DNA and circulating tumour DNA in head and neck squamous cell carcinoma---A systematic review. Mutation research. Reviews in mutation research 2023 11 108477. Xiaomin Huang, Paul Leo, Lee Jones, Pascal Hg Duijf, Gunter Hartel, Lizbeth Kenny, Sarju Vasani, Chamindie Punyadee |
Association of preoperative and postoperative circulating tumour DNA (ctDNA) with PIK3CA gene mutation with risk of recurrence in patients with non-metastatic breast cancer. Surgical oncology 2024 4 54 102060. Fara Hassan, Jiang Huai Wang, Donal Peter O'Leary, Mark Corrigan, Henry Paul Redmo |
Non-invasive decision support for clinical treatment of non-small cell lung cancer using a multiscale radiomics approach. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2024 1 191 110082. Xingping Zhang, Guijuan Zhang, Xingting Qiu, Jiao Yin, Wenjun Tan, Xiaoxia Yin, Hong Yang, Hua Wang, Yanchun Zha |
Clinical-Molecular characteristics and Post-Translational modifications of colorectal cancer in north China: Implications for future targeted therapies. Gene 2024 1 899 148134. Yajing Chi, Hongtu Yuan, Qing Fan, Zhendan Wang, Zuoxing Niu, Jinming Yu, Dandan Yu |
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane. British journal of cancer 2024 1 . Hélène Vanacker, Isabelle Treilleux, Camille Schiffler, Ivan Bieche, Mario Campone, Anne Patsouris, Monica Arnedos, Paul H Cottu, Jean-Philippe Jacquin, Florence Dalenc, Antoine Pinton, Nicolas Servant, Valéry Attignon, Etienne Rouleau, Alain Morel, François Legrand, Marta Jimenez, Fabrice Andre, Thomas Bachel |
TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary Thyroid Carcinoma in a Colombian Cohort. Advances in therapy 2024 1 . Sergio D Cruz-Romero, Sebastián González, José Y Juez, David S Becerra, Ana M Baldión, José A Hakim, Deyanira González-Devia, Sandra Perdomo, Paula A Rodríguez-Urre |
Genomic Alterations of Tumors in HER2-Low Breast Cancers. International journal of molecular sciences 2024 1 25 (2): . Yi-Fang Tsai, Chi-Cheng Huang, Chih-Yi Hsu, Chin-Jung Feng, Yen-Shu Lin, Ta-Chung Chao, Jiun-I Lai, Pei-Ju Lien, Chun-Yu Liu, Jen-Hwey Chiu, Ling-Ming Tse |
Efficacy and Safety of Phosphatidylinositol 3-kinase Inhibitors for Patients with Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Current cancer drug targets 2024 1 . Yi Wang, Xianling Du, Hongqiang Xin, Ruimin |
Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancers. British journal of cancer 2024 1 . Yi Wang, Misi He, Tiancong He, Xueyan Ouyang, Xuxia Shen, Wanling Shi, Shengling Huang, Libing Xiang, Dongling Zou, Wei Jiang, Huijuan Ya |
Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatments. BMC cancer 2024 1 24 (1): 85. Mirai Ido, Kimihito Fujii, Hideyuki Mishima, Akihito Kubo, Masayuki Saito, Hirona Banno, Yukie Ito, Manami Goto, Takahito Ando, Yukako Mouri, Junko Kousaka, Tsuneo Imai, Shogo Naka |
A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy. International journal of molecular sciences 2024 1 25 (1): . Karen Gambaro, Maud Marques, Suzan McNamara, Mathilde Couetoux du Tertre, Cyrla Hoffert, Archana Srivastava, Anna Schab, Thierry Alcindor, Adrian Langleben, Lucas Sideris, Mahmoud Abdelsalam, Mustapha Tehfe, Felix Couture, Gerald Batist, Petr Kav |
Genomic Landscape of Endometrial, Ovarian, and Cervical Cancers in Japan from the Database in the Center for Cancer Genomics and Advanced Therapeutics. Cancers 2024 1 16 (1): . Qian Xi, Hidenori Kage, Miho Ogawa, Asami Matsunaga, Akira Nishijima, Kenbun Sone, Kei Kawana, Katsutoshi O |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: